Reported number of people receiving antiretroviral therapy in Brazil
Brazil: Reported number of people receiving antiretroviral therapy was 853,234 in 2025. ◆ Volatile
Reported number of people receiving antiretroviral therapy in Brazil, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for reported number of people receiving antiretroviral therapy in Brazil is 853,234, measured in 2025. That is the highest value across all 26 years on record.
That represents a change of up 5.6% on the previous year and up 92.8% over ten years.
Over the whole period, reported number of people receiving antiretroviral therapy in Brazil peaked at 853,234 in 2025 and was at its lowest, 89,281, in 2000.
Brazil ranks 10th of 143 countries on this measure, in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Reported number of people receiving antiretroviral therapy in Brazil, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 89,281 | — |
| 2001 | 108,182 | +21.2% |
| 2002 | 119,241 | +10.2% |
| 2003 | 133,678 | +12.1% |
| 2004 | 149,737 | +12.0% |
| 2005 | 166,500 | +11.2% |
| 2006 | 166,637 | +0.1% |
| 2007 | 176,841 | +6.1% |
| 2008 | 187,045 | +5.8% |
| 2009 | 198,503 | +6.1% |
| 2010 | 224,891 | +13.3% |
| 2011 | 264,674 | +17.7% |
| 2012 | 297,604 | +12.4% |
| 2013 | 336,456 | +13.1% |
| 2014 | 385,952 | +14.7% |
| 2015 | 442,616 | +14.7% |
| 2016 | 486,276 | +9.9% |
| 2017 | 536,137 | +10.3% |
| 2018 | 583,804 | +8.9% |
| 2019 | 629,352 | +7.8% |
| 2020 | 654,035 | +3.9% |
| 2021 | 688,978 | +5.3% |
| 2022 | 720,982 | +4.6% |
| 2023 | 766,870 | +6.4% |
| 2024 | 808,346 | +5.4% |
| 2025 | 853,234 | +5.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 149,564 | 89,281 | 198,503 | 10 |
| 2010s | 418,776 | 224,891 | 629,352 | 10 |
| 2020s | 748,741 | 654,035 | 853,234 | 6 |
Countries ranked near Brazil
More health data for Brazil
- Un projection of annual infant deaths, annual growth rate -1.86 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1539 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,496 deaths per 1,000 people (2090)
- Number of infants who die before age 1 3,476 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.66 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0296 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.63 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is reported number of people receiving antiretroviral therapy in Brazil?
- Reported number of people receiving antiretroviral therapy in Brazil was 853,234 in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest reported number of people receiving antiretroviral therapy recorded in Brazil?
- The highest recorded value was 853,234 in 2025.
- What is the lowest reported number of people receiving antiretroviral therapy recorded in Brazil?
- The lowest recorded value was 89,281 in 2000.
- How does Brazil rank for reported number of people receiving antiretroviral therapy?
- Brazil ranks 10th out of 143 countries with data for 2025.
- Is reported number of people receiving antiretroviral therapy rising or falling in Brazil?
- Over the last ten years it is up 92.8%. The long-run trend across the full record is volatile.
- Where does this Brazil data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Reported number of people receiving antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).